Variant report
Variant | esv2764144 |
---|---|
Chromosome Location | chr9:8009205-8021065 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:107727967..107730044-chr9:8019737..8022718,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000110660 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369703473 | chr9:8011405-8011406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568573604 | chr9:8011422-8011423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112352736 | chr9:8011428-8011429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571721461 | chr9:8011472-8011473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34686268 | chr9:8011473-8011474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397694263 | chr9:8011479-8011480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs398113197 | chr9:8011480-8011481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372995603 | chr9:8011481-8011482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531078877 | chr9:8011496-8011497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554290223 | chr9:8011516-8011517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529672889 | chr9:8011533-8011534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs10976717 | chr9:8011579-8011580 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs533584947 | chr9:8011591-8011592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558791518 | chr9:8011601-8011602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10758921 | chr9:8011603-8011604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs138967756 | chr9:8011639-8011640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148971908 | chr9:8011650-8011651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs202003322 | chr9:8011669-8011670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76343052 | chr9:8011670-8011671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79232438 | chr9:8011671-8011672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574734004 | chr9:8011680-8011681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543137274 | chr9:8011701-8011702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs561261600 | chr9:8011719-8011720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10976718 | chr9:8011802-8011803 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs10815739 | chr9:8011813-8011814 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs143829982 | chr9:8011849-8011850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114373181 | chr9:8011855-8011856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148174387 | chr9:8011857-8011858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569104242 | chr9:8011870-8011871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530271206 | chr9:8011922-8011923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547865041 | chr9:8011958-8011959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575242200 | chr9:8011966-8011967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377117769 | chr9:8011982-8011983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533750359 | chr9:8012021-8012022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544330691 | chr9:8012037-8012038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs180953910 | chr9:8012040-8012041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145971383 | chr9:8012044-8012045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574251928 | chr9:8012062-8012063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538137067 | chr9:8012114-8012115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556540621 | chr9:8012151-8012152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12337058 | chr9:8012166-8012167 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs542076856 | chr9:8012169-8012170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574544711 | chr9:8012170-8012171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9408722 | chr9:8012194-8012195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551311638 | chr9:8012211-8012212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369223127 | chr9:8012221-8012222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150097981 | chr9:8012224-8012225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186085794 | chr9:8012235-8012236 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs79089176 | chr9:8012250-8012251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190990135 | chr9:8012304-8012305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Schizophrenia | 23813976 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:8011400-8012400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr9:8011800-8012400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr9:8011800-8012400 | Enhancers | Brain Substantia Nigra | brain |
4 | chr9:8012000-8012400 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr9:8012000-8012600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr9:8012400-8012600 | Enhancers | Placenta Amnion | Placenta Amnion |
7 | chr9:8012400-8021400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
8 | chr9:8012600-8013200 | Weak transcription | Placenta Amnion | Placenta Amnion |
9 | chr9:8013200-8014400 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr9:8014400-8015400 | Weak transcription | Placenta Amnion | Placenta Amnion |
11 | chr9:8015400-8015800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
12 | chr9:8015400-8016000 | Enhancers | Placenta Amnion | Placenta Amnion |
13 | chr9:8015600-8016000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr9:8020000-8020600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr9:8020200-8020600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |